Combination tobevibart 300 mg + elebsiran 200 mg q4w achieved HDV RNA TND in 77% at week 72 and 88% at week 96, outperforming tobevibart monotherapy. Profound HBsAg lowering occurred with dual therapy ...
Long-term safety was stable without emergent signals; grade ≥3 TRAEs stayed ~57–59%, while cumulative neuropathy increased with duration, managed via interruptions and EV dose reductions. Notably, ...
Young readers deserve our best work. The Writing for Children and Young Adults concentration is part of The New School’s MFA Creative Writing program, founded in 1996. Students study with our ...
Your browser does not support iframes. Since its inaugural season of 2007-08, the Big Ten Network has provided unprecedented access to an extensive schedule of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results